AX9 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Akebia Therapeutics Inc

Watchlist Manager

Watchlist

Price: 1.07 EUR -14.64% Market Closed

Market Cap: €356.3m

A	Akebia Therapeutics Inc SWB:AX9	US
I	IGM Financial Inc F:C7G	CA
S	Skechers USA Inc XBER:SKAA	US
	Werner Enterprises Inc NASDAQ:WERN	US

Profitability Summary

Akebia Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

79%

Strong 3Y Average Gross Margin

83%

Declining Gross Margin

80% > 79%

Low Operating Margin

Negative 3Y Average Operating Margin

-14%

Operating Margin is Increasing

-46% > 2%

Negative Net Margin

-9%

Negative 3Y Average Net Margin

-24%

Net Margin is Increasing

-51% > -9%

Exceptional Free Cash Flow Margin

22%

Negative 3Y Average Free Cash Flow Margin

-9%

Free Cash Flow Margin is Increasing

-17% > 22%

Negative ROE

-79%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-11%

ROIC is Increasing

-34% > 3%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.